CG-Well Intervention for Caregivers of Traumatic Brain Injury Patients
(CG-Well Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new program called CG-Well, designed to support caregivers of individuals who have recently experienced a moderate to severe traumatic brain injury (msTBI). The goal is to determine if this program helps caregivers feel better prepared, less stressed, and healthier overall by providing tools and support immediately after the injury. Participants will either use the CG-Well program or receive standard support from the Brain Injury Association of America. Ideal participants are English-speaking caregivers of msTBI survivors who are less than two weeks post-injury and are encountering challenges in their new caregiving role. As an unphased trial, this study offers caregivers a unique opportunity to access potentially beneficial support tools early in their caregiving journey.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the CG-Well intervention is safe for caregivers of traumatic brain injury patients?
Research shows that the CG-Well program is a web and phone-based support system for family caregivers of individuals with traumatic brain injuries. This program emphasizes emotional and social support, avoiding medication or medical procedures, which typically reduces the risk of physical side effects. The main goal is to teach caregivers how to find information, gain education, and receive support.
As this trial is in an early stage, no previous trial data confirms its safety regarding side effects. However, because it involves no physical procedures, it is generally considered safe. Participants might experience improvements in quality of life and reduced stress or depression.
Prospective participants should know that the program aims to help caregivers feel more supported and prepared, potentially benefiting both the caregiver and the person they care for.12345Why are researchers excited about this trial?
Researchers are excited about the CG-Well intervention because it offers a fresh approach to supporting caregivers of traumatic brain injury (TBI) patients. Unlike standard care options that may focus primarily on the TBI patients themselves, CG-Well is a web and phone-based psychosocial program designed specifically for caregivers. It teaches them how to access information, education, and support, which can be crucial in managing stress and improving their quality of life. This unique focus on caregivers is what sets CG-Well apart and could lead to better overall outcomes for both caregivers and patients.
What evidence suggests that the CG-Well intervention is effective for caregivers of traumatic brain injury patients?
Research shows that the CG-Well program, one of the interventions in this trial, is designed to improve the overall well-being of caregivers for people with traumatic brain injuries (TBI). Caregivers often face high stress and poor health. Early studies suggest that providing specific education and support can help them manage these challenges more effectively. CG-Well aims to teach caregivers how to cope with stress soon after the injury, potentially reducing depression and enhancing their quality of life. Although data collection on CG-Well's effectiveness is ongoing, the program appears promising by offering proactive support during critical care transitions. Another group in this trial will receive Information Support and Referral, serving as an attention control group, with phone calls and modules from the Brain Injury Association of America.14567
Are You a Good Fit for This Trial?
This trial is for adult caregivers of patients with moderate to severe traumatic brain injuries (msTBI) that occurred less than 2 weeks ago. Both the caregiver and patient must be over 18, speak English, and the patient should have a GCS score between 3-12 after resuscitation. Those not expected to survive, pregnant individuals, prisoners, or those with conditions like substance abuse or major neurological/mental health disorders cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Caregivers participate in the CG-Well intervention, which includes web and phone-based psychosocial support and education
Follow-up
Participants are monitored for satisfaction, retention, and changes in depressive symptoms and life changes
What Are the Treatments Tested in This Trial?
Interventions
- CG-Well
- Information Support & Referral (ISR)
CG-Well is already approved in United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Natalie Kreitzer
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator